Emma Aarnio

Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease

Wawruch, Martin; Petrova, Miriam; Tesar, Tomas; Murin, Jan; Schnorrerova, Patricia; Paduchova, Martina; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Alfian, Sofa D.; Aarnio, Emma. 2023. Frontiers in pharmacology. 14: . 1199669

New terminology of medication adherence enabling and supporting activities: ENABLE terminology

Kardas, Przemyslaw; Aarnio, Emma; Agh, Tamas; van Boven, Job FM; Dima, Alexandra Lelia; Ghiciuc, Cristina Mihaela; Kamberi, Fatjona; Petrova, Guenka Ivanova; Nabergoj Makovec, Urska; Trečiokienė, Indrė. 2023. Frontiers in pharmacology. 14: . 1254291

Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study

Aarnio, Emma; Huupponen, Risto; Martikainen, Janne; Korhonen, Maarit J. 2023. Exploratory research in clinical and social pharmacy. 11:

Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Petrova, Miriam; Paduchova, Martina; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Masarykova, Lucia; Alfian, Sofa D.; Aarnio, Emma. 2023. Biomedicines. 11:

Suomalaisväestön maksuhalukkuus terveyteen liittyvästä elämänlaadusta

Hakuri, Maija; Aarnio, Emma; Martikainen, Janne; Kankaanpää, Eila. 2023. Sosiaalilääketieteellinen aikakauslehti. 60: 276–288

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes

Lavikainen, Piia; Aarnio, Emma; Linna, Miika; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne. 2022. PLoS ONE. 17:

Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Masarykova, Lucia; Alfian, Sofa D.; Aarnio, Emma. 2022. Biomedicines. 10:

Muutokset tyypin 2 diabetespotilaiden maksamissa lääkkeiden omavastuissa vuoden 2017 lääkekorvausmuutoksen jälkee

Parkkila, Ville; Lavikainen, Piia; Martikainen, Janne; Aarnio, Emma . 2022. Dosis. 38: 214–234

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study

Ágh, Tamás; Hadžiabdić, Maja Ortner; Garuoliene, Kristina; Granas, Anne Gerd; Aarnio, Emma; Menditto, Enrica; Gregório, João; Barnestein-Fonseca, Pilar; Mevsim, Vildan; Kardas, Przemysław. 2022. Frontiers in pharmacology. 13:

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Biomedicines. 9: 1800

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Jalkanen, Kari; Järvenpää, Riia; Tilles-Tirkkonen, Tanja; Martikainen, Janne; Aarnio, Emma; Männikkö, Reija; Rantala, Eeva; Karhunen, Leila; Kolehmainen, Marjukka; Harjumaa, Marja; Poutanen, Kaisa; Ermes, Miikka; Absetz, Pilvikki; Schwab, Ursula; Lakka, Timo; Pihlajamäki, Jussi; Lindström, Jaana; The StopDia Study Group. 2021. JMIR diabetes. 6: e21356

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla

Ojala, Oona; Aarnio, Emma; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne; Lavikainen, Piia. 2021. Lääkärilehti. 76: 48-52

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Frontiers in pharmacology. 12: 687549

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Jalkanen, Kari; Aarnio, Emma; Lavikainen, Piia; Lindström, Jaana; Peltonen, Markku; Laatikainen, Tiina; Martikainen, Janne. 2021. Bmc health services research. 21: 916

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Biomedicines. 9: 1280

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Härkönen, Ulla; Rannanheimo, Piia; Leppänen, Laura; Aarnio, Emma. 2021. Sic!. : 5 s,

Vaikuttavuuden vuosikymmentä rakentamassa : Kansallinen sosiaali- ja terveydenhuollon vaikuttavuuskeskus -selvitys

Torkki, Paulus; Mäki-Opas, Tomi; Vanhala, Antero; Auvinen, Terhi; Aarnio, Emma; Pitkänen, Laura; Linnosmaa, Ismo; Leskelä, Riikka-Leena; Paronen, Elsa; Malmivaara, Antti; Lammintakanen, Johanna; Martikainen, Janne; Heiskanen, Jari. 2021. . . Helsingin yliopisto; Itä-Suomen yliopisto

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

Wawruch, Martin; Wimmer Jr, Gejza; Murin, Jan; Paduchova, Martina; Tesar, Tomas; Hlinkova, Lubica; Slavkovsky, Peter; Aarnio, Emma. 2020. Drugs and aging. 37: 595-604

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Aarnio, Emma; Huupponen, Risto; Martikainen, Jaana E; Korhonen, Maarit J. 2020. Research in social and administrative pharmacy. 16: 553-559

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Lavikainen, Piia; Aarnio, Emma; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne. 2020. Bmc health services research. 20: 1095

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Wawruch, Martin; Wimmer, Gejza Jr; Murin, Jan; Paduchova, Martina; Petrova, Miriam; Tesar, Tomas; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2020. Biomedicines. 8: 378

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Lavikainen, Piia; Aarnio, Emma; Niskanen, Leo; Mäntyselkä, Pekka; Martikainen, Janne. 2020. Health policy. 124: 1310-1316

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Sääskilahti, Maria; Aarnio, Emma; Lämsä, Elina; Ahonen, Riitta; Timonen, Johanna. 2020. Journal of pharmaceutical health services research. 11: 335-342

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Törmälehto, S; Aarnio, E; Mononen, ME; Arokoski, JPA; Korhonen, RK; Martikainen, JA. 2019. PLoS ONE. 14: e0219902

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

Jalkanen, K; Aarnio, E; Lavikainen, P; Jauhonen, HM; Enlund, H; Martikainen, J. 2019. Health and quality of life outcomes. 17: 117

Methodological Considerations in Pharmacoepidemiology and Pharmacovigilance Studies

Koponen, Marjaana; Ilomäki, Jenni; Aarnio, Emma; Taipale, Heidi. Teoksessa: Babar, Zaheer-Ud-Din(toim.) , 2019. Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Volume 2. s. 435-444. Academic press

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

Wawruch M; Wimmer G Jr; Murin J; Paduchova M; Tesar T; Hlinkova L; Slavkovsky P; Fabryova L; Aarnio E. 2019. Drugs and aging. 36: 863-873

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Suviranta, T; Timonen, J; Martikainen, J; Aarnio, E. 2019. Bmc health services research. 19: 769

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Törmälehto, Soili; Mononen, Mika E; Aarnio, Emma; Arokoski, Jari P A; Korhonen, Rami K; Martikainen, Janne. 2018. Health and quality of life outcomes. 16: 154

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Aarnio, Emma; Huupponen, Risto; Hämeen-Anttila, Katri; Merikoski, Merja; Puhakka, Jaana; Korhonen, Maarit J. 2018. Basic and clinical pharmacology and toxicology. 2019; 124: 416-422

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Aarnio Emma. 2017. Publications of the University of Eastern Finland. Dissertations in Health Sciences

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Aarnio Emma, Martikainen Janne. 2016. Sic!. 6: 48-49

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Aarnio Emma, Martikainen Janne, Winn Aaron N, Huupponen Risto, Vahtera Jussi, Korhonen Maarit J. 2016. Circulation: cardiovascular quality and outcomes. 9: 704-713

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Aarnio Emma, Korhonen Maarit J, Huupponen Risto, Martikainen Janne. 2015. Atherosclerosis. 239: 240-247

Measurement of statin exposure in the absence of information on prescribed doses

Romppainen Tomi, Rikala Maria, Aarnio Emma, Korhonen Maarit J, Saastamoinen Leena K, Huupponen Risto. 2014. European journal of clinical pharmacology. 70: 1275-1276

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events

Helin-Salmivaara Arja, Lavikainen Piia, Aarnio Emma, Huupponen Risto, Korhonen Maarit J. 2014. PLoS ONE. 9: e90325

Register-based predictors of adherence among new statin users in Finland

Aarnio Emma J, Martikainen Janne A, Helin-Salmivaara Arja, Huupponen Risto K, Hartikainen Juha E.K, Peura Piia K, Korhonen Maarit J. 2013. Journal of clinical lipidology. 2014:8: 117-125

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Purmonen Timo, Pänkäläinen Emma, Turunen Juha, Asseburg Christian, Martikainen Janne. 2011. Acta oncologica. 50: 344 - 352

Refine your search

Research groups

Projects

Keywords

Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease

New terminology of medication adherence enabling and supporting activities: ENABLE terminology

Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study

Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease

Suomalaisväestön maksuhalukkuus terveyteen liittyvästä elämänlaadusta

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes

Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease

Muutokset tyypin 2 diabetespotilaiden maksamissa lääkkeiden omavastuissa vuoden 2017 lääkekorvausmuutoksen jälkee

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Insuliinihoidon aloittamisen ajankohta ja perusteet ­ tyypin 2 diabetekseen sairastuneilla

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Vaikuttavuuden vuosikymmentä rakentamassa : Kansallinen sosiaali- ja terveydenhuollon vaikuttavuuskeskus -selvitys

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

Methodological Considerations in Pharmacoepidemiology and Pharmacovigilance Studies

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Measurement of statin exposure in the absence of information on prescribed doses

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events

Register-based predictors of adherence among new statin users in Finland

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla